Avid Bioservices Inc (CDMO)

[Protector]

4OR, if it is then the reason is that PtdSer targeting as long as it includes an immune response (the FC-Gamma binding) will NEVER be approaved and will be blocked by BP.

In China it will be on the market within less then 5 Years, if not 2 years.
Simple, you fly in and having treatment in China brings medical Tourism.

It will be cheaper then in the US and China has shown that with Honk-Kong Macao, etc they know how to open that door.

Probably to only way to beat BP at its own game.

AIMO